Skip to main content
. 2013 Mar 25;2013:297921. doi: 10.1155/2013/297921

Table 2.

Detailed information on oncological data.

Patients Tumor stage Grading Positive lymph nodes Recurrent disease Median Follow-up (months)
FIGO I FIGO II FIGO III G1 G2 G3
Endometrial cancer 16 13 (81%) 0 3 (19%) 0 12 (75%) 4 (25%) 4 (25%) 2 (13%) 22 (13–28)
Cervical cancer 19 18 (95%) 1 (5%) 0 2 (11%) 14 (74%) 3 (16%) 5 (26%) 1 (5%) 20 (12–28)